Reversible inhibitor

Reversible inhibitors compete with substrates for occupancy of the active site and include agents that (a) bind to hydrophobic regions of the active site, (b) coordinate to the heme iron atom, or 

Maria Almira Correia Department of Cellular and Molecular Pharmacology, Department of Pharmaceutical Chemistry, Department of Biopharmaceutical Sciences and the Liver Center, University of California, San Francisco, CA. Paul R. Ortiz de Monteiiano Department of Pharmaceutical Chemistry, and Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA. 

Cytochrome P4S0 Structure, Mechanism, and Biochemistry, 3e, edited by Paul R. Ortiz de Monteiiano Kluwer Academic / Plenum Publishers, New York, 2005. 

We have already dealt with the subject of irreversible inhibitors under enzyme titration and location of the active site (Section 11.4.3.2). The phenomenon of reversible inhibition involves simple complexation of the inhibitor with the enzyme at a site which modifies the reactivity of the enzyme catalysis. 

Equation 11.16 is analogous to the Michaelis-Menten equation and changing [I] affects the apparent Km parameter but has no effect on Vjnax- The competitive inhibitor effect is observed graphically in families of Eadie-Hofstee plots where the lines intersect at Vmax on the y-axis, Fig. 11.12. 

Non-competitive inhibition is indicated by an Eadie-Hofstee plot with parallel lines (Fig. 11.13A). 

---

Elucidating Mechanisms for the Inhibition of Enzyme Catalysis An inhibitor interacts with an enzyme in a manner that decreases the enzyme s catalytic efficiency. Examples of inhibitors include some drugs and poisons. Irreversible inhibitors covalently bind to the enzyme s active site, producing a permanent loss in catalytic efficiency even when the inhibitor s concentration is decreased. Reversible inhibitors form noncovalent complexes with the enzyme, thereby causing a temporary de-... 

Herbicidal Inhibition of Enzymes. The Hst of known en2yme inhibitors contains five principal categories group-specific reagents substrate or ground-state analogues, ie, rapidly reversible inhibitors affinity and photo-affinity labels suicide substrate, or inhibitors and transition-state, or reaction-intermediate, analogues, ie, slowly reversible inhibitors (106). 

The anainoacridines, tacrine (19) and its 1-hydroxy metaboUte, velnacrine (20), are reversible inhibitors of AChE. Tacrine was synthesi2ed in the 1940s and has been used clinically for the treatment of myasthenia gravis and tardive dyskinesia (115). Placebo-controUed studies have indicated modest efficacy of tacrine to treat AD dementia (122,123) and in 1993 the dmg was recommended for approval by the PDA under the trade name Cognex. Tacrine (19) has been shown to interact with sites other than AChE, such as potassium channels (124) and muscarinic receptors. However, these interactions are comparatively weak and are not thought to contribute to the biological activity of the dmg at therapeutic levels (115). 

Treatment of Major Depression. Dmgs commonly used for the treatment of depressive disorders can be classified heuristicaHy iato two main categories first-generation antidepressants with the tricycHc antidepressants (TCAs) and the irreversible, nonselective monoamine—oxidase (MAO) inhibitors, and second-generation antidepressants with the atypical antidepressants, the reversible inhibitors of monoamine—oxidase A (RIMAs), and the selective serotonin reuptake inhibitors (SSRIs). Table 4 fists the available antidepressants. 

Reversible Inhibitors of Monoamine Oxidase. Selective MAO-A inhibitors, which aie leveisible (so-called RIMAs), have also been developed, theiefoie substantially leduciag the potential foi food and dmg iateiactions. Indeed, the tyiamine-potentiating effects of these dmgs is much reduced compared with the irreversible MAO inhibitors. The RIMAs represent effective and safer alternatives to the older MAO inhibitors. The only marketed RIMAs ate toloxatone [29218-27-7] and moclobemide (55). The latter is used widely as an effective, weU-tolerated antidepressant. 

Biochemical studies showed that the a-aminoadipoyl analogue derived from (2,3)-P-methylenepenam was not a substrate for expandase activity but rather, it was a potent reversible inhibitor of the ring expansion of (7.-aminoadipoy1-penici11in into deacetoxycephalosporanic acid by the expandase enzyme... 

Reversible inhibition is characterized by an equiUbrium between enzyme and inhibitor. Many reversible inhibitors are substrate analogues, and bear a close relationship to the normal substrate. When the inhibitor and the substrate compete for the same site on the enzyme, the inhibition is called competitive inhibition. In addition to the reaction described in equation 1, the competing reaction described in equation 3 proceeds when a competitive inhibitor I is added to the reaction solution. 

An adjacent tnfluoromethyl group sharply increases the electrophilic character of the carbonyl carbon Compounds that readily form hydrates and hemiacetals show a time-dependent reversible mhibition of the en yme acetylcholinesterase (equation 2), in which the tight complex makes inhibition only partially reversible [75] In comparison with a nonfluormated analogue, several aliphatic ketones flanked by CFj and CF2 groups, are exceptionally potent reversible inhibitors of acetylcholinesterase, as documented by companson of inhibition constants shown in equation 3 [16 ... 

Enzyme inhibitors are classified in several ways. The inhibitor may interact either reversibly or irreversibly with the enzyme. Reversible inhibitors interact with the enzyme through noncovalent association/dissociation reactions. In contrast, irreversible inhibitors usually cause stable, covalent alterations in the enzyme. That is, the consequence of irreversible inhibition is a decrease in the concentration of active enzyme. The kinetics observed are consistent with this interpretation, as we shall see later. 

It was known that the K+ -competitive imidazopyridine compound, SCH28080, inhibits acid secretion. Then, many reversible inhibitors were developed. These contain protonatable nitrogens but have a variety of core structures such as imidazopyiidines, piperidinopyr-idines, substituted 4-phenylaminoquinolines, pyrrolo [3,2-c]quinolines, guanidinothiazoles, and 2,4-diamino-pyrimidine derivatives. Several reversible inhibitors have been in clinical trials. 

The term pseudosubstrate as used in this article will comprise sugar-related compounds that are chemically transformed by glycosidases, often forming long-lived intermediates and thereby acting as reversible inhibitors. Even in cases of weak inhibition, where the intermediate is too short-lived for chemical or physical characterization, the type of reaction catalyzed by the... 

Because of their lack of selectivity and their irreversible inhibition of MAO, the first MAOIs to be developed presented a high risk of adverse interactions with dietary tyramine (see Chapter 20). However, more recently, drugs which are selective for and, more importantly, reversible inhibitors of MAO-A (RIMAs) have been developed (e.g. moclobemide). These drugs are proving to be highly effective antidepressants which avoid the need for a tyramine-free diet. 

Figure 20.2 The chemical structure of some well-known MAO inhibitors. Most of these drugs irreversibly inhibit both MAOa and MAOb but reversible inhibitors (RIMAs), such as moclobemide, inhibit MAOa only...

Both these predictions are borne out by clinical experience despite the snag that only MAOb is found in serotonergic neurons (Saura et al. 1996). So far, there is no explanation for this anomaly. However, the lack of a tyramine-induced pressor effect with moclobemide probably owes more to the fact that it acts as a reversible inhibitor of MAOa (RIMA) than to its isoenzyme selectivity. Its reversible inhibition of MAOa means that, should tyramine ever accumulate in the periphery, it will displace... 

Da Prada, M, Kettler, R, Keller, HH, Burkard, WP, Muggli-Maniglio, D and Haefely, WE (1989) Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A. /. Pharmacol. Exp. Ther. 248 400-414. 

Although cytochalasin B normally functions as a reversible inhibitor of glucose transport, upon exposure to ultraviolet light a small proportion of the bound cytochalasin B molecules become covalently linked to the transporter protein [128-130]. Photolabelling is inhibitable by D-glucose and other transported sugars but not by... 

Flnoromethane has been nsed as a selective inhibitor of ammoninm oxidation and nitrification-linked synthesis of N2O in Nitrosomonas europaea (Miller et al.l993), while difluoromethane has been proposed as a reversible inhibitor of methanotrophs (Miller et al. 1998). 

It is well known that H O is a reversible inhibitor (15) for the removal ofNO by methane over Co-ZSM5. In order to determine whether a similar effect was observable in the bimetallic samples, 3% HjO was cofed to a flow containing 1000 ppm of NO and 1000 ppm of CH with 2% O at 450°C. The results obtained for Co are summarized in Fig. 5. It is worth noting that an almost 60% de-... 

The reversible inhibitors of monoamine oxidase (RIMAs) brofaramine and meclobemide have been studied with mixed results.48 Neither is approved for use in the United States, but they are available in Canada. 

---